AGP Picks
View all

The Boston Examiner
Provided by AGP

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 12, 2026

Aura Biosciences to Participate in Upcoming Investor Conferences
May 12, 2026

Aura Biosciences to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Molecular Partners Reports Financial Results and Highlights for Q1 2026, with Clinical Studies Initiated on MP0712 and MP0317
May 12, 2026

Molecular Partners Reports Financial Results and Highlights for Q1 2026, with Clinical Studies Initiated on MP0712 and MP0317

Indeterminate GlobeNewswire
AI-Powered Crop Micronutrients Market Attracts $3.15 Billion in Investment, Driven by Precision Agriculture Revolution
May 12, 2026

AI-Powered Crop Micronutrients Market Attracts $3.15 Billion in Investment, Driven by Precision Agriculture Revolution

Indeterminate GlobeNewswire
HUBG ALERT: Hub Group Investigated for Securities Fraud; Investors Should Contact Block & Leviton to Potentially Recover Losses
May 12, 2026

HUBG ALERT: Hub Group Investigated for Securities Fraud; Investors Should Contact Block & Leviton to Potentially Recover Losses

Indeterminate GlobeNewswire
Ahold Delhaize USA Appoints Vipin Gopal to Lead Data and AI
May 12, 2026

Ahold Delhaize USA Appoints Vipin Gopal to Lead Data and AI

Indeterminate GlobeNewswire
EARNED Signs Washington Nationals Prospect Miguel Sime Jr. as Brand Ambassador
May 12, 2026

EARNED Signs Washington Nationals Prospect Miguel Sime Jr. as Brand Ambassador

Indeterminate GlobeNewswire
Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease
May 12, 2026

Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease

Indeterminate GlobeNewswire
Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel’s Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026
May 12, 2026

Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel’s Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026

Indeterminate GlobeNewswire
Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress
May 12, 2026

Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress

Indeterminate GlobeNewswire
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress
May 12, 2026

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress

Indeterminate GlobeNewswire
Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias
May 12, 2026

Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias

Indeterminate GlobeNewswire
Rapid7 Launches Cyber Governance, Risk, and Compliance (GRC) Early Access Program to Unify Security Data, Risk Context, and Compliance Workflows
May 12, 2026

Rapid7 Launches Cyber Governance, Risk, and Compliance (GRC) Early Access Program to Unify Security Data, Risk Context, and Compliance Workflows

Indeterminate GlobeNewswire
AI Adoption Accelerates in Accounting, Yet Fragmented Tools Keep Efficiency Just Out of Reach, According to New Progress Software Report
May 12, 2026

AI Adoption Accelerates in Accounting, Yet Fragmented Tools Keep Efficiency Just Out of Reach, According to New Progress Software Report

Indeterminate GlobeNewswire
Tier One Partners Named to PRovoke Media’s 2026 Best Agencies Lists
May 12, 2026

Tier One Partners Named to PRovoke Media’s 2026 Best Agencies Lists

Indeterminate GlobeNewswire
MKS Inc. Declares Quarterly Cash Dividend
May 12, 2026

MKS Inc. Declares Quarterly Cash Dividend

Indeterminate GlobeNewswire
71% of Organizations Suffered At Least One Identity Breach in the Past Year, Sophos Research Finds
May 12, 2026

71% of Organizations Suffered At Least One Identity Breach in the Past Year, Sophos Research Finds

Indeterminate GlobeNewswire
Fortis Life Sciences Awards 2026 AbNano® VHH Discovery Grant to Deliver Biosciences for Targeted Drug Delivery Research
May 12, 2026

Fortis Life Sciences Awards 2026 AbNano® VHH Discovery Grant to Deliver Biosciences for Targeted Drug Delivery Research

Indeterminate GlobeNewswire
Akari Therapeutics Secures Key European Patent For Its Novel RNA Splicing Modulator ADC Payload, Strengthening Global IP Estate For All Major Global Markets
May 12, 2026

Akari Therapeutics Secures Key European Patent For Its Novel RNA Splicing Modulator ADC Payload, Strengthening Global IP Estate For All Major Global Markets

Indeterminate GlobeNewswire
Byrna Technologies Sets Upcoming Investor Conference Schedule
May 12, 2026

Byrna Technologies Sets Upcoming Investor Conference Schedule

Indeterminate GlobeNewswire
Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update
May 12, 2026

Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.